Literature DB >> 10233941

Quantitative analysis of latent human cytomegalovirus.

B Slobedman1, E S Mocarski.   

Abstract

Cytomegalovirus latency depends on an interaction with hematopoietic cells in bone marrow and peripheral blood. The distribution of viral DNA was investigated by PCR-driven in situ hybridization (PCR-ISH), and the number of viral genomes per cell was estimated by quantitative competitive PCR during both experimental and natural latent infection. During experimental latent infection of cultured granulocyte-macrophage progenitors, the viral genome was detected in >90% of cells at a copy number of 1 to 8 viral genomes per cell. During natural infection, viral genomes were detected in 0.004 to 0.01% of mononuclear cells from granulocyte colony-stimulating factor-mobilized peripheral blood or bone marrow from seropositive donors, at a copy number of 2 to 13 genomes per infected cell. When evaluated by reverse transcription-PCR-ISH, only a small proportion of experimentally infected cells (approximately 2%) had detectable latent transcripts. This investigation identifies the small percentage of bone marrow-derived mononuclear cells that become latently infected during natural infection and suggests that latency may proceed in some cells that fail to encode currently identified latent transcripts.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10233941      PMCID: PMC112523     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Epstein-Barr virus genomes with properties of circular DNA molecules in carrier cells.

Authors:  A Adams; T Lindahl
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

3.  Peripheral blood CD14(+) cells from healthy subjects carry a circular conformation of latent cytomegalovirus genome.

Authors:  C A Bolovan-Fritts; E S Mocarski; J A Wiedeman
Journal:  Blood       Date:  1999-01-01       Impact factor: 22.113

4.  Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time.

Authors:  S Larsson; C Söderberg-Nauclér; F Z Wang; E Möller
Journal:  Transfusion       Date:  1998-03       Impact factor: 3.157

5.  A method for the covalent attachment of cells to glass slides for use in immunohistochemical assays.

Authors:  J A Maples
Journal:  Am J Clin Pathol       Date:  1985-03       Impact factor: 2.493

6.  Characterization of EBV-carrying B-cell populations in healthy seropositive individuals with regard to density, release of transforming virus and spontaneous outgrowth.

Authors:  N Lewin; P Aman; M G Masucci; E Klein; G Klein; B Oberg; H Strander; W Henle; G Henle
Journal:  Int J Cancer       Date:  1987-04-15       Impact factor: 7.396

7.  Insertion and deletion mutagenesis of the human cytomegalovirus genome.

Authors:  R R Spaete; E S Mocarski
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

8.  Latent cytomegalovirus infection in blood donors.

Authors:  P Diosi; E Moldovan; N Tomescu
Journal:  Br Med J       Date:  1969-12-13

9.  Quantitative detection of human cytomegalovirus DNA in lung transplant recipients.

Authors:  A T Kotsimbos; V Sinickas; E M Glare; D S Esmore; G I Snell; E H Walters; T J Williams
Journal:  Am J Respir Crit Care Med       Date:  1997-10       Impact factor: 21.405

10.  Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors.

Authors:  C Söderberg-Nauclér; K N Fish; J A Nelson
Journal:  Cell       Date:  1997-10-03       Impact factor: 41.582

View more
  118 in total

Review 1.  Quantitative molecular analysis of virus expression and replication.

Authors:  M Clementi
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Distinct and separate roles for herpesvirus-conserved UL97 kinase in cytomegalovirus DNA synthesis and encapsidation.

Authors:  D G Wolf; C T Courcelle; M N Prichard; E S Mocarski
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

3.  Random, asynchronous, and asymmetric transcriptional activity of enhancer-flanking major immediate-early genes ie1/3 and ie2 during murine cytomegalovirus latency in the lungs.

Authors:  N K Grzimek; D Dreis; S Schmalz; M J Reddehase
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

4.  Macrophages escape inhibition of major histocompatibility complex class I-dependent antigen presentation by cytomegalovirus.

Authors:  H Hengel; U Reusch; G Geginat; R Holtappels; T Ruppert; E Hellebrand; U H Koszinowski
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  Identification of human herpesvirus 6 latency-associated transcripts.

Authors:  Kazuhiro Kondo; Kazuya Shimada; Junji Sashihara; Keiko Tanaka-Taya; Koichi Yamanishi
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

6.  Human cytomegalovirus latency-associated protein pORF94 is dispensable for productive and latent infection.

Authors:  K L White; B Slobedman; E S Mocarski
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

7.  Association of detectable cytomegalovirus (CMV) DNA in monocytes rather than positive CMV IgG serology with elevated neopterin levels in community-dwelling older adults.

Authors:  Sean X Leng; Huifen Li; Qian-Li Xue; Jing Tian; Xi Yang; Luigi Ferrucci; Neal Fedarko; Linda P Fried; Richard D Semba
Journal:  Exp Gerontol       Date:  2011-04-13       Impact factor: 4.032

8.  Recognition of a novel stage of betaherpesvirus latency in human herpesvirus 6.

Authors:  Kazuhiro Kondo; Junji Sashihara; Kazuya Shimada; Masaya Takemoto; Kiyoko Amo; Hiromi Miyagawa; Koichi Yamanishi
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

9.  Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus.

Authors:  Laura Hertel; Vashti G Lacaille; Herbert Strobl; Elizabeth D Mellins; Edward S Mocarski
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

10.  Experimental human cytomegalovirus latency in CD14+ monocytes.

Authors:  Danna Hargett; Thomas E Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.